Zymergen
PublicZymergen is now publicly traded
The data on this page reflects Zymergen's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Apr 26, 2021
Last Round
Bankruptcy
Oct 3, 2023
Total Funding Raised
$1.76B
Company Overview
Zymergen is a biotechnology and materials science company that creates innovative microbe-based inputs and technologies for agricultural and industrial applications.
Sector
Biotech
AI Layer
Infrastructure
Keywords
Zymergen Comparables
Compare Zymergen with similar companies based on industry and business-model similarity.
No public comparables are available for Zymergen. Request access to learn about comparables coverage.
Request accessZymergen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Bankruptcy | Oct 3, 2023 | ||||
| M&A | Oct 19, 2022 | ||||
| IPO | Apr 26, 2021 | ||||
| Series D | Sep 8, 2020 | ||||
| Series C | Dec 13, 2018 | ||||
Series B | Oct 11, 2016 |
Zymergen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series B |
| SoftBank Investment Advisers | Series D, Series C |
| Threshold Ventures | Series A |
| ICONIQ Capital | Series B |
| Perceptive Advisors | Series D |
| Union Square Ventures | Series A |
| Innovation Endeavors | Series B, Series C, Series A |
Zymergen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access